Skip to main content
OpenTrials

Clinical trial condition

Blood Coagulation Disorders

Explore clinical trials studying Blood Coagulation Disorders. Study availability and eligibility vary by location and protocol.

1,498 public trials 249 recruiting studies
Refine in advanced search Browse all conditions

Blood Coagulation Disorders trial results

Recruiting

A Study of Efgartigimod IV in Participants From 12 Years to Less Than 18 Years of Age With Chronic Immune Thrombocytopenia (ITP)

NCT07194850

Conditions
Autoimmune Diseases, Blood Coagulation Disorders, Blood Platelet Disorders, +22 more
Locations
  • Centre Hospitalier Universitaire de Bordeaux Groupe Hospitalier Pellegrin Hopital des Enfants Bordeaux, France
  • Charite - Universitaetsmedizin Berlin - Campus Virchow-Klinikum (CVK) Berlin, Germany
  • Gaslini Children's Hospital Genoa, Italy
  • Fondazione IRCCS San Gerardo dei Tintori Monza, Italy
View all 22 locations
View Trial Details
Recruiting

A Study of Pirtobrutinib in Participants With Immune Thrombocytopenia

NCT06721013

Conditions
Autoimmune Diseases, Blood Coagulation Disorders, Blood Platelet Disorders, +16 more
Locations
  • USC Norris Comprehensive Cancer Center Los Angeles, California, United States
  • MedStar Georgetown University Hospital Washington D.C., District of Columbia, United States
  • University of Miami Hospital and Clinics Sylvester Comprehensive Cancer Center Miami, Florida, United States
  • Bleeding and Clotting Disorders Institute Peoria, Illinois, United States
View all 43 locations
View Trial Details
Recruiting

A Clinical Study to Evaluate the Effects of NXT007 Compared to Factor VIII Prophylaxis in Participants With Hemophilia A

NCT07416526

Conditions
Blood Coagulation Disorders, Blood Coagulation Disorders, Inherited, Coagulation Protein Disorders, +6 more
Locations
  • Nara Medical University Hospital Kashihara-shi, Nara, Japan
  • Tokyo Medical University Hospital Shinjuku-Ku, Tokyo, Japan
  • University of Colorado Hemophilia and Thrombosis Center Aurora, Colorado, United States
  • University of Iowa Hospitals and Clinics Iowa City, Iowa, United States
View all 32 locations
View Trial Details
Recruiting

A Study to Learn About How Safe BAY 3389934 is, Its Suitable Dose, and How it Affects the Participants With Sepsis Induced Coagulopathy

NCT06854640

Conditions
Blood Coagulation Disorders, Cardiovascular Diseases, Coagulopathy, +13 more
Locations
  • Centre Hospitalier Universitaire (CHU) de Liege - Domaine Universitaire du Sart Tilman - Intensive Care Liège, Belgium
  • CHRU de Tours - Hôpital Bretonneau - Médecine Intensive Réanimation Tours, Centre-Val de Loire, France
  • Hopitaux Universitaires de Strasbourg Nouvel Hopital Civil - Service de Médecine Intensive Réanimation Strasbourg, Grand Est, France
  • Centre Hospitalier Universitaire de Limoges Dupuytren 1 - Service de réanimation polyvalente Limoges, New Aquitaine, France
View all 21 locations
View Trial Details
Recruiting

A Clinical Trial of Study Medicine (Marstacimab) in Pediatric Patients With Hemophilia A or Hemophilia B

NCT05611801

Conditions
Blood Coagulation Disorders, Blood Coagulation Disorders, Inherited, Coagulation Protein Disorders, +11 more
Locations
  • Arbesu Hematología Mendoza, Argentina
  • Murdoch Children's Research Institute Parkville, Australia
  • Medizinische Universität Wien Vienna, State of Vienna, Austria
  • Tongji Hospital of Tongji Medical College of Huazhong University of Science and Technology Wuhan, Hubei, China
View all 63 locations
View Trial Details
Recruiting

A Study to Test a Medicine (Fitusiran) for Preventing Bleeds in People With Severe Hemophilia Who Previously Received Preventive Treatment With Emicizumab

NCT06145373

Conditions
Blood Coagulation Disorders, Blood Coagulation Disorders, Inherited, Coagulation Protein Disorders, +6 more
Locations
  • Children's Hospital Los Angeles- Site Number : 8400005 Los Angeles, California, United States
  • Southern Specialty Research- Site Number : 8400011 Flowood, Mississippi, United States
  • Investigational Site Number : 1580001 Taipei, Taiwan
View Trial Details
Recruiting

Safety and Preliminary Efficacy of CTX112 in Adult Participants With Relapsed/Refractory Hematologic Autoimmune Disease

NCT07549698

Conditions
Autoimmune Diseases, Blood Coagulation Disorders, Blood Platelet Disorders, +19 more
Locations
  • Mayo Clinic in Rochester Rochester, Minnesota, United States
  • University of Nebraska Medical Center Omaha, Nebraska, United States
  • Universitaetsklinikum Koeln Cologne, Germany
  • Medizinische Hochschule Hannover Hannover, Germany
View Trial Details
Recruiting

HMBeacon: A Phase 2 Study to Evaluate ALN-6400 in Adult and Adolescent Female Patients With VWD and HMB

NCT07575308

Conditions
Blood Coagulation Disorders, Blood Coagulation Disorders, Inherited, Blood Platelet Disorders, +21 more
Locations
  • Clinical Trial Site Miami, Florida, United States
  • Clinical Trial Site Orange, California, United States
  • Clinical Trial Site Lexington, Kentucky, United States
  • Clinical Trial Site San Diego, California, United States
View Trial Details
Recruiting

A Study to Assess the Tolerability of Ianalumab (VAY736) With Investigator's Choice Thrombopoietin Receptor Agonist (IC TPO-RA) in Patients With Primary Immune Thrombocytopenia (ITP)

NCT07421167

Conditions
Autoimmune Diseases, Blood Coagulation Disorders, Blood Platelet Disorders, +18 more
Locations
  • Stamford Hospital Stamford, Connecticut, United States
  • Baptist MD Anderson Cancer Center Jacksonville, Florida, United States
  • DH Cancer Research Center LLC Margate, Florida, United States
  • Hope And Healing Care Hinsdale, Illinois, United States
View all 13 locations
View Trial Details

Related conditions